Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-04

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using Umbilical Cord Mesenchymal Stem Cells for primary sclerosing cholangitis in Phase 1 and Phase 2. Sponsor is Fuzhou General Hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Primary Sclerosing Cholangitis | Phase 1, Phase 2 | Status: UNKNOWN